Article
Comparative impacts over 5 years of artemisinin-based combination therapies on Plasmodium falciparum polymorphisms that modulate drug sensitivity in Ugandan children.
The Journal of infectious diseases - 1 Aug 2014
Conrad Melissa D, LeClair Norbert, Arinaitwe Emmanuel, Wanzira Humphrey, Kakuru Abel, Bigira Victor, Muhindo Mary, Kamya Moses R, Tappero Jordan W, Greenhouse Bryan, Dorsey Grant, Rosenthal Philip J
Abstract excerpt
BACKGROUND: Artemisinin-based combination therapies, including artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP), are recommended to treat uncomplicated falciparum malaria. Sensitivities to components of AL and DP are impacted by polymorphisms in pfmdr1 and pfcrt. We monitored changes in prevalences of polymorphisms in Tororo, Uganda, from 2008 to 2012. METHODS: Polymorphic loci in pfmdr1 and...
Topics
- Alleles
- Artemisinins
- Child, Preschool
- Drug Resistance
- Female
- Humans
- Infant
- Malaria, Falciparum
- Male
- Plasmodium falciparum
